Impaired IFNγ production may be a main contributor to postoperative formation of cancer metastases and understanding the changes in NK cell biology responsible for impaired IFNγ is essential for the development of effective perioperative immunotherapeutics for patients undergoing cancer surgery. The gene discussed is IFNG; the disease is cancer.